A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the RYR2 Gene
Abstract
1. Introduction
2. Case Description
3. Discussion
3.1. Difficulties in Diagnosis—The Role of Genetics
3.2. Therapeutic Issues
4. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Priori, S.G. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J. 2015, 36, 2793–2867. [Google Scholar] [PubMed]
- Stepien-Wojno, M. Sudden cardiac arrest in patients without overt heart disease: A limited value of next generation sequencing. Pol. Arch. Intern. Med. 2018, 128, 721–730. [Google Scholar] [CrossRef] [PubMed]
- Stępień-Wojno, M. A different background of arrhythmia in siblings with a positive family history of sudden death at young age. Ann. Noninvasive Electrocardiol. 2019, e12707. [Google Scholar] [CrossRef]
- Emery, M.S.; Kovacs, R.J. Sudden Cardiac Death in Athletes. JACC Heart Fail. 2018, 6, 30–40. [Google Scholar] [CrossRef]
- Hayashi, M. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009, 119, 2426–2434. [Google Scholar] [CrossRef]
- Lieve, K.V.; van der Werf, C.; Wilde, A.A. Catecholaminergic Polymorphic Ventricular Tachycardia. Circ. J. 2016, 80, 1285–1291. [Google Scholar] [CrossRef]
- Medeiros-Domingo, A. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: A comprehensive open reading frame mutational analysis. J. Am. Coll. Cardiol. 2009, 54, 2065–2074. [Google Scholar]
- Van der Werf, C. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J. Am. Coll. Cardiol. 2011, 57, 2244–2254. [Google Scholar] [CrossRef]
- Ohno, S.; Hasegawa, K.; Horie, M. Gender Differences in the Inheritance Mode of RYR2 Mutations in Catecholaminergic Polymorphic Ventricular Tachycardia Patients. PLoS ONE 2015, 10, e0131517. [Google Scholar] [CrossRef]
- Shigemizu, D. Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes. PLoS ONE 2015, 10, e0130329. [Google Scholar] [CrossRef]
- Domingo, D. Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia. Rev. ESP Cardiol. 2015, 68, 398–407. [Google Scholar] [CrossRef] [PubMed]
- Okudaira, N. A knock-in mouse model of N-terminal R420W mutation of cardiac ryanodine receptor exhibits arrhythmogenesis with abnormal calcium dynamics in cardiomyocytes. Biochem. Biophys. Res. Commun. 2014, 452, 665–668. [Google Scholar] [CrossRef] [PubMed]
- Baltogiannis, G.G. CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief. Review of the Literature. Front. Cardiovasc. Med. 2019, 6, 92. [Google Scholar] [CrossRef] [PubMed]
- Willis, B.C. Constitutive Intracellular Na+ Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation 2016, 133, 2348–2359. [Google Scholar] [CrossRef]
- Ostby, S.A. Competitive Sports Participation in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia: A Single Center’s Early Experience. JACC Clin. Electrophysiol. 2016, 2, 253–262. [Google Scholar] [CrossRef]
- Postma, A.V. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J. Med. Genet. 2005, 42, 863–870. [Google Scholar] [CrossRef]
- Sumitomo, N. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ. J. 2007, 71, 1606–1609. [Google Scholar] [CrossRef]
- Miyake, C.Y. Circadian Variation of Ventricular Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia. JACC Clin. Electrophysiol. 2017, 3, 1308–1317. [Google Scholar] [CrossRef]
- Pflaumer, A. 50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)—Time to Explore the Dark Side of the Moon. Heart Lung Circ. 2020, 29, 520–528. [Google Scholar] [CrossRef]
- Leren, I.S. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2016, 13, 433–440. [Google Scholar] [CrossRef]
- Van der Werf, C. Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest. Eur. Heart J. 2019, 40, 2953–2961. [Google Scholar] [CrossRef] [PubMed]
- Dusi, V. Cardiac Sympathetic Denervation in Channelopathies. Front. Cardiovasc. Med. 2019, 6, 27. [Google Scholar] [CrossRef] [PubMed]
- Roses-Noguer, F. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2014, 11, 58–66. [Google Scholar] [CrossRef] [PubMed]
- Probst, V. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper. Arch. Cardiovasc. Dis. 2020, 113, 359–366. [Google Scholar] [CrossRef]
- Rudic, B. Low Prevalence of Inappropriate Shocks in Patients with Inherited Arrhythmia Syndromes with the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up. J. Am. Heart Assoc. 2017, 6, e006265. [Google Scholar] [CrossRef]
- Kannankeril, P.J. Atropine-induced sinus tachycardia protects against exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. Europace 2020, 22, 643–648. [Google Scholar] [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Stępień-Wojno, M.; Ponińska, J.; Biernacka, E.K.; Foss-Nieradko, B.; Chwyczko, T.; Syska, P.; Płoski, R.; Bilińska, Z.T. A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the RYR2 Gene. Diagnostics 2020, 10, 435. https://doi.org/10.3390/diagnostics10070435
Stępień-Wojno M, Ponińska J, Biernacka EK, Foss-Nieradko B, Chwyczko T, Syska P, Płoski R, Bilińska ZT. A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the RYR2 Gene. Diagnostics. 2020; 10(7):435. https://doi.org/10.3390/diagnostics10070435
Chicago/Turabian StyleStępień-Wojno, Małgorzata, Joanna Ponińska, Elżbieta K. Biernacka, Bogna Foss-Nieradko, Tomasz Chwyczko, Paweł Syska, Rafał Płoski, and Zofia T. Bilińska. 2020. "A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the RYR2 Gene" Diagnostics 10, no. 7: 435. https://doi.org/10.3390/diagnostics10070435
APA StyleStępień-Wojno, M., Ponińska, J., Biernacka, E. K., Foss-Nieradko, B., Chwyczko, T., Syska, P., Płoski, R., & Bilińska, Z. T. (2020). A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the RYR2 Gene. Diagnostics, 10(7), 435. https://doi.org/10.3390/diagnostics10070435